Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.38% is 57% below its 5-year average of 5.55%, near the low end of its 5-year range (1.46%–14.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 60.18% below its 12-month average of 5.97%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.38%.
DEBT TO ASSETS RATIO
2.38%
DEBT TO ASSETS RATIO AVG TTM
5.97%
DEBT TO ASSETS RATIO AVG 3Y
7.21%
DEBT TO ASSETS RATIO AVG 5Y
5.55%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-60.18%
CURRENT VS 3Y AVG
-67.01%
CURRENT VS 5Y AVG
-57.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 584 covered companies
CURRENT VS SECTOR MEDIAN
+2278.43%
vs the sector median at left
Biomea Fusion, Inc.
Market Cap
$90.37M
Debt to Assets Ratio
2.38%
TTM Avg
5.97%
3Y Avg
7.21%
5Y Avg
5.55%
Market Cap
$90.20M
Debt to Assets Ratio
0.27%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.55M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.98M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.20M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $90.37M | 2.38% | 5.97% | 7.21% | 5.55% |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 0.27% | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $89.15M | 0.01% | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $92.89M | 0.56% | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 0.58% | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.55M | 0.01% | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $94.86M | 0.26% | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $84.98M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.20M | 0.01% | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.03M | 0.48% | N/A | N/A | N/A |
Debt/Assets
2.4%
Debt/Equity
0.07
Current Ratio
3.47
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.38% |
| 2026-03-31 | 2.67% |
| 2025-12-31 | 2.71% |
| 2025-09-30 | 12.46% |
| 2025-06-30 | 9.64% |
| 2025-03-31 | 14.40% |
| 2024-12-31 | 10.97% |
| 2024-09-30 | 8.66% |
| 2024-06-30 | 7.60% |
| 2024-03-31 | 6.58% |
| 2023-12-31 | 5.15% |
| 2023-09-30 | 5.37% |
| 2023-06-30 | 5.12% |
| 2023-03-31 | 11.85% |
| 2022-12-31 | 1.77% |
| 2022-09-30 | 1.68% |
| 2022-06-30 | 1.59% |
| 2022-03-31 | 1.55% |
| 2021-12-31 | 1.53% |
| 2021-09-30 | 1.50% |
| 2021-06-30 | 1.46% |
| 2021-03-31 | 0.29% |
| 2020-12-31 | 0.41% |
